Hormone replacement therapy [topp]
urinary [qlco]
Albumin [aapp, bacs]
Excretion [phsf]
postmenopausal [tmco]
diabetic [fndg]
Women [popg]
months [tmco]
Combined [qlco]
Continuous [idcn]
Hormone replacement therapy [topp]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
Albumin/creatinine ratio [lbpr]
postmenopausal [tmco]
diabetic [fndg]
Women [popg]
Controlled Study [resa]
Interquartile Range [qnco]
Plasma [bdsu]
Albumin/creatinine ratio [lbpr]
P NOS [aapp, imft]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
mg/g [qnco]
N NOS [aapp, imft]
Compared [acty]
placebo [topp]
mg/g [qnco]
N NOS [aapp, imft]
Proportion [qnco]
Women [popg]
Microalbuminuria [dsyn]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
baseline [bodm]
End [spco]
Study [mnob]
Several [qnco]
risk factors [qnco]
Microalbuminuria [dsyn]
Including [ftcn]
Systolic blood pressure [clna]
Fasting blood glucose [lbpr]
Glycated haemoglobin [aapp, bacs]
adiposity [dsyn]
Hormone replacement therapy [topp]
Suggest [idcn]
months [tmco]
Hormone replacement therapy [topp]
Reverse [idcn]
Microalbuminuria [dsyn]
Prolonged [tmco]
Hyperglycaemia [dsyn]
risk factors [qnco]
Leakage [patf]
Albumin [aapp, bacs]
Urine [bdsu]
postmenopausal [tmco]
Women [popg]
Type 2 Diabetes [dsyn]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
